Sage Journals: Discover world-class research

Abstract

Objective:

We examined whether miR-21-5p activates the PI3K/AKT/mTOR signaling pathway, thereby inhibiting autophagy and apoptosis induced by H₂O₂ in AEC II cells.

Introduction:

MicroRNA and autophagy play crucial roles in important biological processes during hyperoxia-induced acute lung injury. Located on chromosome 17q23.1, miR-21-5p, as a critical component of the miRNAs family, significantly contributes to the regulation of cell growth, apoptosis, and autophagy. However, the underlying mechanism through which miR-21-5p suppresses H₂O₂-induced autophagy and apoptosis of primary AEC-II in vitro remains to be fully elucidated.

Methods:

To investigate the regulatory role of miR-21-5p in autophagy, primary type II alveolar epithelial cells (AEC-II) were isolated from rat lung tissue and subjected to 0.5 mmol/L H₂O₂ in a cell culture environment to simulate hyperoxia-induced acute lung injury. Cell viability was detected by cell counting Kit 8. Reactive oxygen species and apoptosis were detected by flow cytometry. Autophagy levels in AEC-II were evaluated by autophagic double marker method. The expressions of apoptosis and autophagy related proteins were detected by Western blotting.

Results:

We found that in the process of H₂O₂ injury of AEC-II, the level of autophagy flow was up-regulated and the expression of miR-21-5p was down-regulated. Overexpression of miR-21-5p can significantly reduce the level of autophagy flow, inhibit apoptosis, and activate the AKT/mTOR signaling pathway.

We pretreated with rapamycin, an mTOR inhibitor, to block the biological effects of miR-21-5p. In addition, pretreatment with MHY1485, an mTOR activator, inhibited AEC-II autophagy flow levels and increased apoptosis.

Conclusion:

In summary, miR-21-5p can inhibit H₂O₂-induced AEC-II apoptosis and autophagy flow, which is partially mediated by the AKT/mTOR signaling pathway.

MiR-21-5p could be used as both a clinical biomarker and a promising molecular target in patients with HALI.

Keywords

hyperoxia-induced actue lung injury type II alveolar epithelial cells MicroRNA-21-5p autophagy apoptosis

Introduction

Hyperoxia-induced actue lung injury (HALI) is a major complication of oxygen therapy in the treatment of critically ill patients. The main pathogenic factors of HALI are hyperoxia-induced alveolar epithelial cells (AEC) and pulmonary vascular endothelial cells injury,¹ and then alveolar structure damage, pulmonary capillary leakage and hyaline membrane formation, which will eventually progress to acute respiratory distress syndrome (ARDS) in adults and bronchopulmonary dysplasia (BPD) in infants.² The overall incidence of HALI in ICU patients is approximately 12%–18%, and it exhibits a positive correlation with the duration of high-oxygen exposure.³ The mortality rate was 35%–40%.⁴ At present, the treatment of HALI is limited to prevention and symptomatic supportive treatment, and there are no effective means. Therefore, effective strategies of treatment are urgently needed to improve prognosis and reduce mortality of patient.

Autophagy is great significance in the physiological process of cells, including the removal of misfolded protein and damaged organelles, so as to maintain the balance of cell metabolism and relieve the stress of cells. Under stress conditions, autophagy can promote cell survival.^5,6 However, excessive autophagy will degrade basic proteins or organelles to promote cell death,⁷ so the biological effects of autophagy have two sides. For example, in the early stage of tumors, autophagy delays tumor progression by maintaining genome integrity and inhibiting inflammation,⁸ while in advanced stages, autophagy promotes the degradation of MHC-I on the surface of cancer cells to facilitate immune evasion, which is not good for patients.^9,10 Studies have shown that the autophagy of lung tissue and AEC-II of newborn mice will be up-regulated under hyperoxia exposure conditions.¹¹ This degradative autophagy has a protective effect, which can limit the death of alveolar epithelial cells.^12,13 In addition, 8-oxoguanine-DNA glycosylase can activate autophagy-related protein 7 (ATG7) to repair DNA and regulate autophagy to reduce hyperoxia-induced alveolar epithelial cell injury.¹⁴ It holds immense importance to investigate the regulation of autophagy in order to prevent and treat lung injury.

miRNA plays an important role in growth, apoptosis and autophagy.^15
–17 In our previous study, miR-21-5p is low level in H₂O₂-induced AEC-II, which is involved in the apoptosis process of AEC-II.¹⁸ miR-21-5p can target PTEN/PI3K/AKT pathway to inhibit AEC-II apoptosis and reduce HALI.^18,19 But the mechanism of PI3K/AKT signaling pathway regulating AEC-II apoptosis in HALI has not been explored. Studies have shown that miR-21-5p can target the PTEN/AKT signaling pathway to inhibit autophagy and apoptosis.²⁰ Nevertheless, all previous experiments were conducted using cell lines, and there is a lack of reports on studies involving primary cells. The subsequent alterations in primary cells are crucial for disease research, therefore, this study investigates whether miR-21-5p can inhibit the apoptosis and autophagy of primary AEC-II under hyperoxic conditions. This may yield more valuable insights for the prevention and provide a new theoretical basis for the clinical treatment of HALI in the future.

Materials and methods

Animal and reagents

This study was approved by the Animal Ethics Committee of the Zunyi Medical University, China (permit#: [2021]2-218). The SPF male Sprague-Dawley (SD) rats were obtained from the Tianqin Biotechnology Company (Changsha, Hunan, China), license number: SCXK (Hunan) 2019-0014, all raised in the SPF laboratory of the Biological Research Center of Zunyi Medical University. The rats were maintained at 18–22°C, a relative humidity of 50%–60% and a 12 h light/dark cycle with free access to rat chow and water. Fetal bovine serum, trypsin and collagenase type I were purchased from the GIBCO Company (USA). The lentiviral vectors of miR-21-5p were purchased from Hanbio Biotechnology (Shanghai, China). The LC3B, p62, c-caspase-3, Bcl2, Bax, PTEN, p-AKT, mTOR, Phospho-mTOR, β-actin and goat anti-rabbit secondary antibodies were purchased from Cell Signaling Technology (USA).

Cell culture

The isolation of AEC-II was performed based on the previous studies.^21
–23 SD rats were anesthetized via intraperitoneal injection of 2% pentobarbital sodium (50 mg/kg). Subsequently, the thoracic cavity was carefully opened, and the lung was promptly excised and placed into sterile Petri dishes for further processing. The lung tissue was digested using a solution containing 0.20% pancreatic enzyme and 0.1% type I collagenase for 15 min. The enzymatic digestion was subsequently terminated by adding medium supplemented with 0.015% DNase I. The lung tissue was sectioned into a 1 mm³ mesh, followed by centrifugation at 377g for 5 min. Subsequently, the cells were transferred to a culture dish containing rat IgG and incubated at 37°C for 1 h. Then, the cells were inoculated and cultured for 48 h, after which they were collected for further experimentation. The purity and survival rates of isolated cells were >90%, indicating that isolated cells could be used for further experiments. We have previously achieved successful simulation of hyperoxia exposure by utilizing 500 mM H₂O₂.²³

Immunofluorescence

AEC II were cultured in a six-well plate with pre-existing cell slides. When AEC II are 50% full of the slide, the cells removed the medium and washed with PBS twice.

After formaldehyde fixation and BSA treatment, the cells washed with PBS twice. The cells were applied with SP-C (1:250, Absin Biotechnology Company, Shanghai, China) antibody and placed in a humid chamber at 4°C overnight. In the dark at room temperature, the cells were stained with the secondary antibody. Finally, the cell slide was observed and photographed under a fluorescence microscope.

Transmission electron microscopy (TEM)

There are two parts of this experiment that require TEM. First, the unique ultrastructural osmophilic lamellar bodies and microvilli of AEC-II were observed by transmission electron microscope. Second, autophagosomes and autophagolysosomes can be detected by TEM.²⁴ The cells were washed with phosphate buffers and then immobilized with electron microscope fixative at 4°C for 12 h. After dehydration in an ethanol solution, the cells were encased in epoxy resin. Samples were sliced and stained with uranyl acetate and lead citrate, then examined under a transmission electron microscope (HT7700, HITACHI, Japan).

CCK-8 assay

Primary AEC-II cells were extracted and inoculated into 96-well plates with 2–3 × 10³ cells/plate. After the simulated hyperoxic exposure was completed, the cells were treated with CCK-8 solution. Cell viability was tested with the cell count kit-8 (Solarbio Life Science Company, Beijing, China).

DCFH-DA (2′,7′-dichlorodihydrofluorescein) fluorimetry

The concentration of reactive oxygen species (ROS) was determined using a flow cytometer (Beckman Coulter, USA). The relevant detection was performed using a commercial ROS assay kit (Invitrogen, Thermo Fisher Scientific, USA).

MicroRNA transfection

The extracted primary AEC-II were plated in Petri dish (6 cm) plates at 2 × 10⁵ cells/plate and cultured overnight. Then, the cells were transfected with the overexpression lentiviral vector of miR-21-5p or a negative control miRNA using culture medium containing polybrene (2 μg/mL), according to the protocol.

Real-time PCR

Total RNA was extracted from the AEC-II using Trizol (Takara Bio, Beijing, China) reagent according to the manufacturer’s protocol (Invitrogen Life Technologies). The forward and reverse primers sequences for miR-21-5p were as follows: 5′-CCGGCTAGCTTATCAGACTGATGTTGA-3′ and 5′-CTCAACTGGTGTCGTGGA-3′. The forward and reverse primers sequences for U6 were as follows: 5′-CTCGCTTCGGCAGCACA-3′ and 5′-AACGCTTCACGAATTTGCGT-3′. The PCR was performed on Bio-Rad CFX96 thermocycler (Bio-Rad, USA). miRNA expression levels were finally normalized to the U6 with the 2^−ΔΔCt method.

Western blotting

Total protein was extracted from AEC-II after different treatments by using lysed buffer (Tissue/cell lysate: PMSF: Phosphorylated protease inhibitor = 1:1:1) on ice. Extracted sample protein were resolved on SDS-PAGE gels and transferred to PVDF membranes. These membranes were treated with blocked and incubated antibodies and quantified using an chemiluminescence-Western blotting detection system (Bio-Rad, USA).

MRFP-GFP-LC3 adenovirus transfection

The extracted primary AEC-II were plated in six-well plates at 2 × 10⁵ cells/plate and cultured overnight and transfected with the autophagic LC3 double-labeled adenovirus using culture medium containing 10% FBS for 6 h, according to the manufacturer’s protocol. The culture medium was replaced by new after 6 h, and the status of infection was observed by confocal microscope at 48 h.

Detection of early apoptotic cells with flow cytometry (FCM)

The AEC-II were collected and resuspended in PBS. After centrifugation, the supernatant was discarded, and 100 μL of 1× binding buffer was added to each sample. The apoptosis detection kit (BD, Shanghai, China) was utilized following the experimental protocol and stained with 0.5 μL Annexin V-FITC/0.5 μL PI at room temperature for 15 min. Subsequently, the samples were analyzed using flow cytometry (Beckman Coulter, USA). Unstained cells were used to establish background fluorescence levels, serving as a negative control. FSC and SSC gates were utilized to select large, highly granular cells while excluding small debris fragments. FITC-conjugated Annexin V, PE-conjugated PI, Annexin V binds to phosphatidylserine, and PI is used for detecting cell membrane integrity. Therefore, living cells are characterized as Annexin V-negative/PI-negative, early apoptotic cells as Annexin V-positive/PI-negative, and late apoptotic or necrotic cells as Annexin V-positive/PI-positive. On a scatter plot, the horizontal axis represents Annexin V staining, while the vertical axis represents PI staining. The plot is divided into four quadrants: D3 indicates living cells, D4 corresponds to early apoptosis, D2 signifies late apoptosis or necrosis, and D1 corresponds to necrotic cells with entirely compromised cell membranes. The number of events were 50,000 cells.

Statistical analysis

SPSS 29.0 statistical software was used for data analysis. Graphpad prism 9.0 was used to draw statistical graphics. The data were presented as the means ± standard deviation and analyzed using independent-samples t-test or one-way analysis of variance followed by the Least Significant Difference post-hoc test for multiple comparisons. ^*p < 0.05, ^**p < 0.01, ^***p < 0.001, ^nsp > 0.05. p < 0.05 was considered to indicate a statistically significant difference.

Results

Identification of AEC II

First, the primary AEC-II cells were extracted and cultured. An inverted phase-contrast microscope was used to observe cells morphology. When the cells were cultured for 24 h, the cells adhered to the bottom of petri dish and grew like islands. During 24–48 h, the cells began to extend to the periphery. The cell adhesion rate could reach more than 95% at 48 h (Figure 1(a)). Next, we used immunofluorescence and TEM to appraise AEC-II. We used immunofluorescence microscope to observe specific protein of AEC-II which SP-C was mainly distributed in the cytoplasm and cell membrane (Figure 1(b)). We also used TEM to observe the unique ultrastructure of AEC-II: microvilli and osmophilic lamellar bodies (Figure 1(c)). These show that the extracted cells are AEC-II.

Figure 1.

Cultivation and identification of AEC II. The primary AEC-II was extracted and identified by immunofluorescence and TEM. (a) When the extracted primary AEC-II cells were cultured to 0 h, 24 h, and 48 h, we used light microscope to observe the cell morphology (bar = 250 μm). (b) When the cells were cultured to 48 h, we used immunofluorescence to identify AEC-II (bar = 25 μm). (c) When the cells were cultured to 48 h, we used TEM to identify AEC-II (bar = 2 μm). The red arrow points to the osmophilic lamellar bodies, the blue arrow points to the microvilli.

Changes of autophagic flux in AEC II after H₂O₂ stimulation

In order to verify whether the autophagic level in AEC-II changes after H₂O₂ treatment. We used WB to detect the expression levels of LC3 and p62 (Figure 2(a)). As shown in Figure 2(b), compared with the 0 h group, the expression of LC3-II/I was up-regulated at each time point, which is a reliable indicator of autophagy.²⁵ Comparing each time point in pairs, the expression of LC3-II/I was the highest in the 2 h group, and there was no difference in the expression of LC3-II/I at 4 h, 8 h, and 12 h. Figure 2(c) shows that the expression of p62 was the lowest at 2 h and the highest at 8 h. These data indicate that the primary AEC-II can be successfully induced to show dynamic changes of autophagic level after H₂O₂ treatment. Among them, p62 as an autophagy adaptor protein,²⁶ most obviously accumulates at the 8 h. Autophagy at 8 h is considered to be an insufficient form of autophagy as previously reported and this form of autophagy can exacerbate damage.¹¹ So the subsequent experimental modeling time is set at 8 h. As shown in Figure 2(d), we observed that cell viability was decreased in the H₂O₂ group compared with control group. We assayed the levels of ROS was up-regulated in AEC-II compared to the control group (Figure 2(e)). Autophagy dual-labeling system was used to evaluate the level of autophagy in cells. Figure 2(f) and (g) show that the number of autophagosomes and autophagolysosomes in the H₂O₂ group increased, compared with the control group. In addition, the autophagy vacuoles and autophagosomes in AEC-II were observed by transmission electron microscopy (Figure 3(a)).

Figure 2.

H₂O₂ treat can activate autophagy level of AEC-II and reduce cell viability, AEC-II treated by H₂O₂ can induce autophagy and the optimal time is at 8 h. (a) Western blot was used to detect the expression level of p62 and LC3 protein of AEC-II in different time (n = 3). (b, c) The statistical graph of expression level of LC3 and p62. LC3-II/LC3-I/β-actin: 1.000 ± 0.068 (0 h), 2.761 ± 0.176 (2 h), 1.899 ± 0.164 (4 h), 2.094 ± 0.122 (8 h), 1.992 ± 0.197 (12 h). p62/β-actin: 1.000 ± 0.002 (0 h), 0.335 ± 0.119 (2 h), 2.130 ± 0.029 (4 h), 2.282 ± 0.019 (8 h), 1.66 ± 0.019 (12 h). (d) The viability of AEC-II was detected using the CCK-8 assay (n = 6). Control: 98.8240 ± 0.827%, H₂O₂: 73.344 ± 4.013%. (e) The level of ROS in AEC-II was detected using the ROS Assay Kit (n = 6). Control: 8.138 ± 1.020, H₂O₂: 37.060 ± 1.708. (f, g) Autophagy-related fluorescence double labeling was used to detect the autophagic level of AEC-II in control and H₂O₂ group (n = 6). Control: 1.67 ± 0.516 Dots (Autophagosom), 1.83 ± 0.753 Dots (Autophagolysome), H₂O₂: 10.00 ± 2.767 Dots (Autophagosom), 40.83 ± 8.329 Dots (Autophagolysome).

Figure 3.

Overexpressing miR-21-5p alleviates autophagy induced by H₂O₂ injury. (a) TEM was used to observe autophagy-related bodies in AEC-II (bar = 2 μm). The red arrow points to the autophagolysosome and the yellow arrow points to the autophagosome. (b) RT-PCR was used to detect miR-21-5p expression levels in each group (n = 3). miR-21-5p/U6: 1.000 ± 0.000 (Control), 0.431 ± 0.010 (H₂O₂), 2.463 ± 0.240 (miR-21-5p+H₂O₂), 0.460 ± 0.029 (Empty vector+H₂O₂). (c) Observation of cell morphology of each group by microscope (bar = 100 μm). (d) Western blot was used to detect the expression level of p62 and LC3 protein of AEC-II in each group (n = 3). (e, f) The statistical graph of expression level of LC3 and p62. LC3-II/LC3-I/β-actin: 1.000 ± 0.016 (Control), 2.426 ± 0.159 (H₂O₂), 1.459 ± 0.037 (miR-21-5p+H₂O₂), 1.459 ± 0.037 (Empty vector+H₂O₂). p62/β-actin: 1.000 ± 0.238 (Control), 1.507 ± 0.010 (H₂O₂), 0.514 ± 0.211 (miR-21-5p+H₂O₂), 1.515 ± 0.012 (Empty vector+H₂O₂). (g) The effect of miR-21-5p overexpression on the vability of AEC-II. 98.660 ± 0.743% (Control), 72.200 ± 3.132% (H₂O₂), 82.950 ± 3.568% (miR-21-5p+H₂O₂), 74.250 ± 4.169% (Empty vector+H₂O₂).

miR-21-5p up-regulation alleviates autophagy induced by H₂O₂ injury

To clarify the role of miR-21-5p in H₂O₂-induced autophagy and apoptosis of AEC-II, we overexpressed miR-21-5p in AEC-II through lentiviral vectors. Immunofluorescence method proved that the best MOI was 50, and the efficiency of flow cytometry was 95.8% ± 0.18%. As shown in Figure 3(b), we observed a significant decrease in the expression level of miR-21-5p (43.2%) in the H₂O₂ group compared to the control group. Conversely, cells transfected with overexpressing miR-21-5p lentiviral vectors exhibited an approximately 6-fold increase in miR-21-5p expression relative to the H₂O₂ group. The H₂O₂ group exhibited a reduction in cell viability, whereas cells overexpressing miR-21-5p demonstrated enhanced resistance to H₂O₂-induced cell damage (Figure 3(c)). Compared to the H₂O₂ group, overexpressing miR-21-5p significantly attenuated autophagy, leading to a notable decrease in the expression levels of LC3-II/LC3-I and p62 protein (Figure 3(d)–(f)). The CCK-8 results also demonstrated that overexpressing miR-21-5pcould ameliorate H₂O₂-induced cellular damage, as compared to the H₂O₂ group (Figure 3(g)).

miR-21-5p can reduce H₂O₂-induced damage by activating AKT/mTOR axis

We aimed to investigate the significance of miR-21-5p-mediated regulation of the AKT/mTOR signaling pathway in AEC-II cells during H₂O₂-induced injury. The effects of an mTOR signaling pathway agonist (MHY1485) and an mTOR signaling pathway inhibitor (rapamycin) on AEC-II cell viability and the expression levels of proteins related to the AKT/mTOR signaling pathway were examined. Our findings demonstrated that H₂O₂ stimulation led to a decrease in PTEN, an apoptosis-related protein, while activating p-AKT and inhibiting p-mTOR. Furthermore, compared to the H₂O₂ group, overexpression of miR-21-5p significantly upregulated both p-AKT and p-mTOR/mTOR levels. (Figure 4(a)–(d)). The cell viability of AEC-II was unaffected by rapamycin treatment at concentrations ranging from 0 nM to 10 nM for 24 h, as demonstrated in Figure 4(e). Similarly, treatment with MHY1485 at concentrations of 0 μM, 1 μM, 2 μM, 5 μM, and 10 μM for either a duration of 4 h or 6 h did not impact cell viability. However, there was a decrease in cell activity observed after the extended duration of treatment (6 h) compared to the shorter duration (4 h) in Figure 4(f). Therefore, a treatment time of 4 h was selected for subsequent experiments involving MHY1485 on AEC-II. In addition, according to the literature,^24,27
–29 the expression levels of mTOR and p-mTOR were assessed by Western blotting in AEC-II treated with rapamycin and MHY1485. Compared to the 0 nM group, there was a significant down-regulation of p-mTOR/mTOR expression at 10 nM, 20 nM, and 100 nM concentrations. The level of p-mTOR/mTOR expression in the 20 nM group was lower than that in the 10 nM group. No difference in p-mTOR/mTOR expression was observed between the 20 nM and 100 nM groups. Therefore, a concentration of 20 nM rapamycin was selected for a subsequent experiment involving a treatment duration of 24 h on AEC-II. (Figure 4(g) and (h)). Compared to the 0 μM group, the expression of p-mTOR/mTOR was upregulated in the 2 μM, 5 μM, and 10 μM groups. However, there were no significant differences observed in p-mTOR/mTOR expression among the 2 μM, 5 μM, and 10 μM groups. Therefore, a concentration of 2 μM MHY1485 was selected for a subsequent 4-h treatment of AEC-II in follow-up experiments (Figure 4(i) and (j)).

Figure 4.

The impact of miR-21-5p on the AKT/mTOR signaling pathway in AEC-II and the effects of rapamycin and MHY1485 on AEC-II activity and mTOR activity. (a)The expression of PTEN, AKT, and mTOR related proteins in each group (n = 3). (b–d) The expression levels of AKT/mTOR pathway related proteins. p-mTOR/β-actin: 1.000 ± 0.081 (Control), 0.556 ± 0.112 (H₂O₂), 0.846 ± 0.026 (miR-21-5p+H₂O₂), 0.532 ± 0.113 (Empty vector+H₂O₂). p-AKT/β-actin: 1.000 ± 0.114 (Control), 1.436 ± 0.057 (H₂O₂), 1.800 ± 0.055 (miR-21-5p+H₂O₂), 1.474 ± 0.060 (Empty vector+H₂O₂). PTEN/β-actin: 1.000 ± 0.025 (Control), 0.816 ± 0.052 (H₂O₂), 0.511 ± 0.140 (miR-21-5p+H₂O₂), 0.808 ± 0.092 (Empty vector+H₂O₂). (e–f) The effect of each concentration on cell viability (The figure (e) is rapamycin; the figure (f) is MHY1485, n = 6). Rapamycin: (0 nM) 101.033 ± 9.040, (1 nM) 102.566 ± 3.934, (10 nM) 99.516 ± 12.267, (20 nM) 101.916 ± 5.071, (40 nM) 102.816 ± 4.152, (60 nM) 98.833 ± 5.110, (80 nM) 96.533 ± 8.021, (100 nM) 99.300 ± 4.534. MHY1485: (0 μM) 101.567 ± 6.005(4 h) 98.367 ± 9.923(6 h), (1 μM) 104.618 ± 6.234(4 h) 87.114 ± 26.670(6 h), (2 μM) 110.027 ± 6.101(4 h) 88.185 ± 33.143(6 h), (5 μM) 112.686 ± 6.701(4 h) 74.463 ± 31.240(6 h), (10 μM) 104.168 ± 0.089(4 h) 87.300 ± 33.671(6 h). (g–h) The expression of mTOR and p-mTOR at various concentrations of rapamycin (n = 3). p-mTOR/β-actin: (0 nM) 0.996 ± 0.008, (10 nM) 0.313 ± 0.036, (20 nM) 0.262 ± 0.032, (100 nM) 0.254 ± 0.005. (i–j) The expression of mTOR and p-mTOR at various concentrations of MHY1485 (n = 3). p-mTOR/β-actin: (0 μM) 1.000 ± 0.077, (2 μM) 1.227 ± 0.100, (5 μM) 1.229 ± 0.091, (10 μM) 1.278 ± 0.138.

The protective effect mediated by miR-21-5p during H₂O₂-induced AEC-II damage can be abolished through the inhibition of mTOR

Next, p-mTOR was inhibited using the mTOR inhibitor rapamycin to determine whether mir-21-5p could activate the AKT/mTOR signaling pathway to regulate apoptosis and autophagy. The data suggested a significant inhibition of p-mTOR/mTOR levels in cells treated with rapamycin, and miR-21-5p fails to activate Akt/mTOR after treatment with rapamycin (Figure 5(a)–(d)). The results depicted in Figure 5(c) and (d) demonstrate that rapamycin enhances autophagy by downregulating p62 expression and upregulating LC3II/I ratio. Notably, the LC3II/I ratio was lower in the Rapa+miR-21-5p+H₂O₂ group compared to the Rapa+H₂O₂ group. However, there were no significant differences observed in p62 expression levels. Based on these findings, it can be concluded that miR-21-5p regulates autophagy through mTOR signaling pathway and plays a role in H₂O₂-induced AEC-II damage. Then, we further investigate alterations in autophagy and apoptosis following mTOR activation. To achieve this, we activated mTOR using MHY1485 to induce p-mTOR and determine whether changes occur in autophagy and apoptosis pathways. Our data revealed a significant increase in p-mTOR/mTOR levels upon treatment with MHY1485. Furthermore, MHY1485 reduced autophagy by decreasing the LC3II/I ratio while increasing p62 expression levels. Interestingly, when comparing the MHY1485+H₂O₂ group with the MHY1485+miR-21-5p+H₂O₂ group, we observed a decrease in p62 expression only within the latter group, however, no statistically significant difference was found regarding LC3II/I ratio (Figure 5(e)–(h)). In addition, miR-21-5p can attenuate apoptosis by downregulating the expression of Bax and c-caspase-3 when compared to the H₂O₂ group. Conversely, the MHY1485+miR-21-5p+H₂O₂ group exhibited elevated levels of Bcl-2, Bax, and c-caspase-3 in comparison to the miR-21-5p+H₂O₂ group (Figure 5(i)–(l)).

Figure 5.

Inhibition of mTOR partially eliminated the protective effect mediated by miR-21-5p. (a) The expression of p62, LC3, and mTOR related proteins in each group (n = 3). (b–d) The expression levels of mTOR, p-mTOR, p62, and LC3 in each group (rapamycin). p-mTOR/β-actin: 1.000 ± 0.011 (Control), 0.837 ± 0.006 (H₂O₂), 0.242 ± 0.032 (Rapa+H₂O₂), 0.303 ± 0.062 (Rapa+miR-21-5p+H₂O₂), 0.831 ± 0.029 (MDSO+H₂O₂). P62/β-actin: 1.000 ± 0.149 (Control), 1.324 ± 0.166 (H₂O₂), 0.158 ± 0.030 (Rapa+H₂O₂), 0.157 ± 0.030 (Rapa+miR-21-5p+H₂O₂), 1.326 ± 0.152 (MDSO+H₂O₂). LC3-II/LC3-I/β-actin: 1.000 ± 0.010 (Control), 1.307 ± 0.126 (H₂O₂), 2.842 ± 0.046 (Rapa+H₂O₂), 2.547 ± 0.215 (Rapa+miR-21-5p+H₂O₂), 1.305 ± 0.131 (MDSO+H₂O₂). (e) The expression of p62, LC3, p-mTOR, and mTOR related proteins in each group (n = 3). (f–h) The expression levels of mTOR, p-mTOR, p62, and LC3 in each group (MHY1485). p-mTOR/β-actin: 1.000 ± 0.007 (Control), 0.916 ± 0.021 (H₂O₂), 1.020 ± 0.020 (MHY1485+H₂O₂), 1.040 ± 0.040 (MHY1485+miR-21-5p+H₂O₂), 0.920 ± 0.018 (MDSO+H₂O₂). P62/β-actin: 1.000 ± 0.004 (Control), 2.276 ± 0.047 (H₂O₂), 2.582 ± 0.025 (MHY1485+H₂O₂), 2.008 ± 0.107 (MHY1485+miR-21-5p+H₂O₂), 2.243 ± 0.080 (MDSO+H₂O₂). LC3-II/LC3-I/β-actin: 1.000 ± 0.006 (Control), 1.081 ± 0.015 (H₂O₂), 0.595 ± 0.028 (MHY1485+H₂O₂), 0.711 ± 0.071 (MHY1485+miR-21-5p+H₂O₂), 1.064 ± 0.170 (MDSO+H₂O₂). (i–l) The expression of Bax, c-caspased-3, and Bcl-2 related proteins in each group (n = 3). Bcl-2/β-actin: 1.000 ± 0.000 (Control), 1.666 ± 0.362 (H₂O₂), 0.628 ± 0.125 (miR-21-5p+H₂O₂), 1.616 ± 0.310 (Empty vector+H₂O₂), 1.358 ± 0.132 (Rapa+H₂O₂), 0.680 ± 0.164 (Rapa+miR-21-5p+ H₂O₂), 2.274 ± 0.263 (MHY1485+H₂O₂), 2.234 ± 0.225 (MHY1485+miR-21-5p+H₂O₂). Bax/β-actin: 1.000 ± 0.000 (Control), 1.365 ± 0.148 (H₂O₂), 0.570 ± 0.099 (miR-21-5p+H₂O₂), 1.357 ± 0.092 (Empty vector+H₂O₂), 1.067 ± 0.108 (Rapa+H₂O₂), 0.941 ± 0.175 (Rapa+miR-21-5p+H₂O₂), 1.388 ± 0.132 (MHY1485+H₂O₂), 1.266 ± 0.222 (MHY1485+miR-21-5p+H₂O₂). c-caspased-3/ β-actin: 1.000 ± 0.000 (Control), 1.352 ± 0.120 (H₂O₂), 0.670 ± 0.129 (miR-21-5p+H₂O₂), 1.357 ± 0.006 (Empty vector+H₂O₂), 1.116 ± 0.140 (Rapa+H₂O₂), 1.151 ± 0.143 (Rapa+miR-21-5p+ H₂O₂), 1.352 ± 0.164 (MHY1485+H₂O₂), 1.330 ± 0.120 (MHY1485+miR-21-5p+H₂O₂).

miR-21-5p can inhibit autophagy by inhibiting the production of autolysosome

Red dots refer to the fact that autolysosomes are markers of autophagy activity, the presence of red dots usually indicates an active autophagy process. They may represent autophagosomes that have fused with lysosomes, indicating that the cell is undergoing material degradation. Green dots usually refer to autophagosomes, and the appearance of green dots represents the formation of autophagosomes, indicating that the cell is capturing and sequestering the process of damaging components or harmful substances within the cell. By detecting red and green dots simultaneously, dynamic changes between autophagosome formation and autophagosome and lysosome fusion can be observed, providing insight into the different stages of autophagy. miR-21-5p decreased the number of autophagosomes and down-regulated autophagy, Rapamycin inhibited mTOR increased the number of autophagosomes and autophagolysosomes and enhanced autophagy. MHY1485 inhibited the number of autophagosomes and autolysosomes and inhibited autophagy. There was no difference in the number of LC3-GFP and LC3-RFP in AEC-II between Rapa+H₂O₂ group and Rapa+miR-21-5p+H₂O₂ group, indicating that rapamycin blocked the down-regulation of autophagy by miR-21-5p. There was no difference in the number of LC3-GFP and LC3-RFP in AEC-II between MHY1485+H₂O₂ group and MHY1485+miR-21-5p+H₂O₂ group, indicating that MHY1485 pretreatment can exert a strong autophagy inhibition effect on AEC-II (Figure 6(a) and (b)). Even overexpression of miR-21-5p could not further inhibit autophagy.

Figure 6.

The effect of activation and inhibition of mTOR on miR-21-5p-mediated AEC-II autophagy during H₂O₂ injury. (a) Changes of LC3-GFP and LC3-RFP points in each group (n = 6). (b) The location of LC3-GFP and LC3-RFP in each group (bar = 15 μm). LC3-GFP: 1.60 ± 0.371 (Control), 10.10 ± 3.107 (H₂O₂), 8.40 ± 3.502 (miR-21-5p+H₂O₂), 8.40 ± 3.240 (Empty vector+H₂O₂), 34.00 ± 8.692 (Rapa+H₂O₂), 31.40 ± 10.856 (Rapa+miR-21-5p+H₂O₂), 2.50 ± 0.972 (MHY1485+H₂O₂), 2.20 ± 0.919 (MHY1485+miR-21-5p+H₂O₂), 9.90 ± 2.767 (MDSO+H₂O₂). LC3-RFP: 1.70 ± 0.396 (Control), 41.20 ± 8.135 (H₂O₂), 24.90 ± 10.082 (miR-21-5p+H₂O₂), 40.50 ± 7.517 (Empty vector+H₂O₂), 88.20 ± 24.453 (Rapa+H₂O₂), 93.30 ± 23.646 (Rapa+miR-21-5p+H₂O₂), 4.10 ± 1.524 (MHY1485+H₂O₂), 3.50 ± 1.179 (MHY1485+miR-21-5p+H₂O₂), 39.30 ± 6.667 (MDSO+H₂O₂).

miR-21-5p can inhibit the early apoptosis of AEC-II and reduce cell damage

The early apoptosis rate of each group was detected by flow cytometry after H₂O₂ treatment. The results showed that H₂O₂ treatment of AEC-II could induce cell apoptosis, and overexpression of miR-21-5p could inhibit the early death rate of AEC-II and alleviate cell damage. The anti-apoptosis effect of miR-21-5p after rapamycin pretreatment was not significant (Figure 7(a) and (b)).

Figure 7.

The effect of activation and inhibition of mTOR on miR-21-5p-mediated AEC-II apoptosis during H₂O₂ injury. (a)The rate of apoptosis of AEC-II in each group. (b) The rate of early apoptosis rate in each group (n = 6). The rate of apoptosis of AEC-II: 0.417 ± 0.147% (Control), 33.950 ± 4.568% (H₂O₂), 16.183 ± 1.081% (miR-21-5p+H₂O₂), 33.683 ± 4.338% (Empty vector+H₂O₂), 26.733 ± 2.673% (Rapa+H₂O₂), 24.967 ± 3.208% (Rapa+miR-21-5p+H₂O₂), 41.417 ± 4.256% (MHY1485+H₂O₂), 37.917 ± 4.681% (MHY1485+miR-21-5p+H₂O₂), 33.317 ± 4.378% (MDSO+H₂O₂).

Discussion

To the best of our knowledge, this study represents the first evidence demonstrating that up-regulation of miR-21-5p can effectively rectify inadequate autophagy in AEC-II induced by H₂O₂ stimulation, which plays a critical role in cellular protection against HALI. The findings from this investigation suggest that miR-21-5p may regulate autophagy through its targeting of the AKT/mTOR signaling pathway. In order to simulate HALI in vitro, primary AEC-II derived from Sprague-Dawley rats were utilized and exposed to H₂O₂ treatment. An assessment of both miR-21-5p expression and autophagic activity within damaged AEC-II. Notably, our results revealed insufficient levels of miR-21-5p expression in H₂O₂-treated AEC-II, overexpression of miR-21-5p was found to effectively modulate autophagy and mitigate H₂O₂-induced damage in these cells.

The process of autophagy is a highly regulated and dynamic mechanism of self-digestion. Autophagy has gained increasing recognition as a multifaceted biological process that is intricately linked to various Neurodegenerative disorders (Alzheimer disease, Parkinson disease, Polyglutamine diseases, etc.),^30
–33 Cardiovascular diseases,³⁴ Musculoskeletal disorders,³⁵ Kidney diseases,³⁶ Metabolic syndromes³⁷ and Pulmonary disorders,³⁸ among others. A significant amount of research has been dedicated to investigating the role of autophagy in lung diseases, such as HALI.^{11,27,39
–42} Under physiological conditions, autophagy exerts a cytoprotective effect and facilitates normal lung function. Autophagy also exhibits an anti-apoptotic role by aiding cellular recovery during HALI, subsequent damage can lead to compromised autophagic activity, which is classified as type II programmed or autophagic cell death.¹¹ Our previous studies showed that inhibiting AEC-II apoptosis could significantly improve lung function after hyperoxia-induced lung injury.¹⁹

The miRNA molecules play a pivotal role in cellular functions, encompassing the regulation of apoptosis, proliferation, migration, and differentiation. The pioneering study conducted by Zhu et al.⁴³ unveiled the involvement of miRNAs in autophagy regulation. The regulation of autophagy is facilitated by miR-30a through the inhibition of Beclin-1 expression, which is mediated by the presence of the miR-30a consensus sequence within the 3′-UTR region of Beclin 1. Consequently, numerous miRNAs have been identified as capable regulators of autophagy through their targeting of miRNAs or other signaling pathways.^44
–46 Recently, Yan et al.²⁰ showed that Inhibition of miR-21-5p targets PTEN and reduces autophagy and migration of keloid fibroblasts. Similarly, a separate study demonstrated that downregulation of miR-21 in nasopharyngeal carcinoma cells not only suppresses cellular proliferation but also induces apoptosis through inhibition of the PI3K/AKT/mTOR signaling pathway.⁴⁷ The present study reveals that miR-21-5p exerts a negative regulatory function on autophagy, primarily through the mediation of the AKT/mTOR signaling pathway.

The PI3K/AKT/mTOR pathway is a classic pathway for autophagy regulation.⁴⁸ mTOR belongs to the PI3K-related protein kinase family, and its C-terminal exhibits homology with PI3K. There are two forms of mTOR: the lysosomal mTOR complex (mTORC1) and the lipid membrane-associated mTOR complex (mTORC2). While mTORC1 is involved in regulating autophagy, mTORC2 governs cytoskeletal processes. The activation of the PI3K/AKT/mTOR signaling pathway exerts a negative regulatory effect on autophagy. Phosphorylation at Ser2448 leads to the activation of p-AKT and subsequent phosphorylation of mTOR, resulting in p-mTOR.⁴⁹ Phagocytic vesicles, the precursor of autophagosomes, are synthesized by ULK1-FIP200-ATG13 complex. p-mTOR directly phosphorylates ULK1 to inhibit the formation of ULK1-FIP200-ATG13 complex to inhibit autophagy.⁵⁰ The target gene of miR-21-5p identified thus far is PTEN.^51
–53 We observed that the overexpression of miR-21-5p resulted in a downregulation of PTEN expression and activation of the PI3K/AKT/mTOR pathway, leading to a reduction in autophagy levels. However, even in the presence of rapamycin, an mTOR inhibitor, miR-21-5p still decreased autophagy activity, suggesting its potential involvement in regulating alternative signaling pathways.

Based on the above results, miR-21-5p regulates autophagy via mTOR, and autophagy may be beneficial to AEC-II. Therefore, we want to observe the changes in autophagy and apoptosis by activating mTOR. MHY1485 was synthesized based on the morpholinotriazine structure that could be combined with mTOR and inhibited autophagy by inducing mTOR activation.⁵⁴ However, we showed that MHY1485 can decrease autophagic level, but amplify AEC-II apoptosis during H₂O₂ injury. When we utilized the mTOR activator MHY1485, miR-21-5p exhibited augmented autophagic activity, implying its potential involvement in the regulation of other signaling pathways. Furthermore, previous investigations have substantiated that miR-21-5p directly binds to Bcl-2 mRNA and attenuates its expression.⁵⁵ The protein Beclin-1 contains the BH3 domain of Bcl-2 homolog, which functions as an inhibitor of autophagy.⁵⁶ The findings of Ma et al.⁵⁷ demonstrated that miR-21 downregulated the expression of Bcl-2 and concurrently upregulated autophagy-associated proteins ATG5, Beclin1, and LC3-I/II. Our findings also demonstrate that miR-21-5p exerts a down-regulatory effect on the expression level of Bcl-2. Moreover, emerging research has increasingly elucidated the pivotal role of members from the RAB small GTPase protein family, renowned as regulators of membrane transport and fusion, in autophagy regulation.^58,59 The findings of a study on traumatic brain injury revealed that miR-21-5p exerts inhibitory effects on autophagy activity by specifically targeting Rab11a, thereby suggesting the potential role of miR-21-5p in regulating autophagy through a novel signaling pathway.⁶⁰

In this study, we conducted preliminary investigations into the role and mechanism of miR-21-5p through in vitro cell experiments. However, future research should include animal experiments involving up-regulation and knockout of miR-21-5p, as well as the knockout or overexpression of mTOR, to better elucidate relationship between miR-21-5p and mTOR with autophagy and apoptosis. After comprehensive analysis, our data demonstrated that miR-21-5p effectively inhibits H₂O₂-induced autophagy and apoptosis of AEC-II cells. This effect may be attributed to the regulation of the AKT/mTOR signaling pathway. Furthermore, rapamycin exhibited significant anti-apoptotic efficacy in our cellular model, warranting further investigation into its specific mechanism. In addition, the sample size was not calculated in this study, which is a limitation. We plan to address this issue and improve it in future experiments by implementing a more rigorous sample size estimation method.

Conclusion

miR-21-5p reduces H₂O₂-induced autophagy and apoptosis of primary AEC-II by partially activating PI3K/AKT/mTOR signaling pathway, thereby alleviating cell damage. Our findings could potentially offer a novel perspective and serve as a robust basis for the clinical management of HALI.

Footnotes

Author contributions

XL and HM designed this study. QD, YR, and BF performed all the experiments and analyzed the data and prepared the figures. YR, JZ, KY, and MC drafted the initial manuscript. HM reviewed and revised the manuscript. All authors read and approved the final manuscript.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was financially supported by the National Natural Science Foundation of China (82160022), Guizhou Provincial Department of Science and Technology (No: ZK-2022-660, No: ZK-2023-544, ZK-2024-299, ZK-2024-320), and Guizhou Provincial Health Commission (gzwkj2024-091, gzwkj2024-310). Zunyi Science and Technology Bureau Science and Technology Fund Project: (2023) No. 221, (2023) No. 199.

Ethical approval

Ethical approval for this study was obtained from * The Animal Ethics Committee of the Zunyi Medical University, China (permit#: [2021]2-218)*.

Animal welfare

The present study followed international, national, and/or institutional guidelines for humane animal treatment and complied with relevant legislation.

Declaration of AI use

We employed [Deepseek] to enhance the grammatical accuracy and readability of the manuscript. All AI-generated suggestions were critically reviewed and approved by us, who retain full responsibility for the final content.

ORCID iD

Hong Mei

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

Cao

Xiao

, et al. (2020) Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death & Differentiation 27(9): 2635–2650.

Wang

Yin

Liu

(2024) Research progress of the role of non-coding RNA in hyperoxia-induced acute lung injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 36(4): 430–434.

Hochberg

Semler

Brower

(2021) Oxygen toxicity in critically ill adults. American Journal of Respiratory and Critical Care Medicine 204(6): 632–641.

Bellani

Laffey

J G

Pham

, et al. (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8): 788–800.

Mochida

Nakatogawa

(2022) ER-phagy: Selective autophagy of the endoplasmic reticulum. EMBO Reports 23(8): e55192.

Liu

Wang

, et al. (2023) TMEM164 is a new determinant of autophagy-dependent ferroptosis. Autophagy 19(3): 945–956.

Liu

Yao

Yang

, et al. (2023) Autophagy: Regulator of cell death. Cell Death & Disease 14(10): 648.

Barnard

Regan

Hansen

, et al. (2016) Autophagy inhibition delays early but not late-stage metastatic disease. The Journal of Pharmacology and Experimental Therapeutics 358(2): 282–293.

Dikic

Elazar

(2018) Mechanism and medical implications of mammalian autophagy. Nature Reviews Molecular Cell Biology 19(6): 349–364.

10.

Fitzwalter

Towers

Sullivan

, et al. (2018) Autophagy inhibition mediates apoptosis sensitization in cancer therapy by relieving FOXO3a turnover. Developmental Cell 44(5): 555–565.e3.

11.

Sureshbabu

Syed

Das

, et al. (2016) Inhibition of regulatory-associated protein of mechanistic target of rapamycin prevents hyperoxia-induced lung injury by enhancing autophagy and reducing apoptosis in neonatal mice. American Journal of Respiratory Cell and Molecular Biology 55(5): 722–735.

12.

Beyer

Norwood Toro

Hughes

, et al. (2021) Autophagy, TERT, and mitochondrial dysfunction in hyperoxia. American Journal of Physiology Heart and Circulatory Physiology 321(5): H985–H1003.

13.

Luo

Sho

, et al. (2019) ROS-induced autophagy regulates porcine trophectoderm cell apoptosis, proliferation, and differentiation. American Journal of Physiology Cell Physiology 316(2): C198–C209.

14.

Lin

Zhang

, et al. (2017) DNA repair interacts with autophagy to regulate inflammatory responses to pulmonary hyperoxia. Journal of Immunology 198(7): 2844–2853.

15.

Jiang

Chen

, et al. (2020) miR-21-5p induces pyroptosis in colorectal cancer via TGFBI. Frontiers in Oncology 10: 610545.

16.

Nasci

Chuppa

Griswold

, et al. (2019) MiR-21-5p regulates mitochondrial respiration and lipid content in H9C2 cells. American Journal of Physiology Heart and Circulatory Physiology 316(3): H710–H21.

17.

Yuan

Yang

Duscher

, et al. (2020) Overexpression of microRNA-21-5p prevents the oxidative stress-induced apoptosis of RSC96 cells by suppressing autophagy. Life Sciences 256: 118022.

18.

Qin

Chen

, et al. (2018) miR‑21‑5p regulates type II alveolar epithelial cell apoptosis in hyperoxic acute lung injury. Molecular Medicine Reports 17(4): 5796–5804.

19.

Qin

Wang

Liu

, et al. (2019) miR‑21‑5p ameliorates hyperoxic acute lung injury and decreases apoptosis of AEC II cells via PTEN/AKT signaling in rats. Molecular Medicine Reports 20(6): 4953–4962.

20.

Yan

Wang

Xiao

, et al. (2020) Inhibition of microRNA-21-5p reduces keloid fibroblast autophagy and migration by targeting PTEN after electron beam irradiation. Laboratory Investigation 100(3): 387–399.

21.

Jansing

Mcclendon

Kage

, et al. (2018) Isolation of rat and mouse alveolar type II epithelial cells. Methods in Molecular Biology 1809: 69–82.

22.

Lin

Tian

Wang

, et al. (2017) Apoptosis and surfactant protein-C expression inhibition induced by lipopolysaccharide in AEC II cell may associate with NF-κB pathway. The Journal of Toxicological Sciences 42(1): 53–61.

23.

Liu

Mei

Chen

, et al. (2019) Protective effect of agmatine against hyperoxia-induced acute lung injury via regulating lncRNA gadd7. Biochemical and Biophysical Research Communications 516(1): 68–74.

24.

Jia

Cao

, et al. (2019) Rapamycin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting IL-1β and IL-18 production. International Immunopharmacology 67: 211–219.

25.

Zhang

Wang

(2020) Effects of high-load exercise induced skeletal muscle injury on autophagy ultrastructure and Beclin1 and LC3-II / I in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 36(4): 296–300.

26.

Zeng

Zhang

, et al. (2022) Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis. Military Medical Research 9(1): 25.

27.

Caro-Vegas

Bailey

Bigi

, et al. (2019) Targeting mTOR with MLN0128 overcomes rapamycin and chemoresistant primary effusion lymphoma. mBio 10(1): e02871-18.

28.

Phan

Kim

Mutsaers

, et al. (2022) Modulation of mTOR signaling by radiation and rapamycin treatment in canine mast cell cancer cells. Canadian Journal of Veterinary Research 86(1): 3–12.

29.

Zhang

Wang

, et al. (2023) Rapamycin attenuates pyroptosis by suppressing mTOR phosphorylation and promoting autophagy in LPS-induced bronchopulmonary dysplasia. Experimental Lung Research 49(1): 178–192.

30.

Choi

Wang

Yoo

, et al. (2023) Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nature Cell Biology 25(7): 963–974.

31.

Lizama

Chu

(2021) Neuronal autophagy and mitophagy in Parkinson’s disease. Molecular Aspects of Medicine 82: 100972.

32.

Minchev

Kazakova

Sarafian

(2022) Neuroinflammation and autophagy in Parkinson’s disease-novel perspectives. International Journal of Molecular Sciences 23(23): 14997.

33.

Zhang

Zhu

Tang

, et al. (2023) Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms. Zoological Research 44(6): 1132–1145.

34.

Gao

Liu

, et al. (2022) Mitochondrial autophagy: Molecular mechanisms and implications for cardiovascular disease. Cell Death & Disease 13(5): 444.

35.

Wang

Deng

, et al. (2020) The role of autophagy and mitophagy in bone metabolic disorders. International Journal of Biological Sciences 16(14): 2675–2691.

36.

Tang

Livingston

Liu

, et al. (2020) Autophagy in kidney homeostasis and disease. Nature Reviews Nephrology 16(9): 489–508.

37.

Zhang

Peng

Yang

, et al. (2022) The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders. Cell Death & Disease 13(2): 132.

38.

Klionsky

D J

Petroni

Amaravadi

, et al. (2021) Autophagy in major human diseases. The EMBO Journal 40(19): e108863.

39.

Huang

Deng

Huang

, et al. (2020) Attenuation of lipopolysaccharide-induced acute lung injury by hispolon in mice, through regulating the TLR4/PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 pathways, and suppressing oxidative stress-mediated er stress-induced apoptosis and autophagy. Nutrients 12(6): 1742.

40.

Qin

Tan

, et al. (2020) Mechanistic target of rapamycin-mediated autophagy is involved in the alleviation of lipopolysaccharide-induced acute lung injury in rats. International Immunopharmacology 78: 105790.

41.

Zhi

Chao

, et al. (2018) ERK1/2/mTOR/Stat3 pathway-mediated autophagy alleviates traumatic brain injury-induced acute lung injury. Biochimica et Biophysica Acta Molecular Basis of Disease 1864(5 Pt A): 1663–1674.

42.

Zeng

, et al. (2018) MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy. Experimental Lung Research 44(2): 89–97.

43.

Zhu

Liu

, et al. (2009) Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 5(6): 816–823.

44.

Ahangari

Price

Malik

, et al. (2023) MicroRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis. JCI Insight 8(4): e158100.

45.

Liu

Yang

, et al. (2020) mIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy 16(4): 683–697.

46.

Xue

Liu

Wang

, et al. (2023) miRNA-103-3p-Hlf regulates apoptosis and autophagy by targeting hepatic leukaemia factor in heart failure. ESC Heart Failure 10(5): 3038–3045.

47.

Xiao

Chen

Cui

(2020) MicroRNA-21 depletion by CRISPR/Cas9 in CNE2 nasopharyngeal cells hinders proliferation and induces apoptosis by targeting the PI3K/AKT/MOTOR signaling pathway. International Journal of Clinical and Experimental Pathology 13(4): 738–745.

48.

Han

, et al. (2020) Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Applied Microbiology and Biotechnology 104(2): 575–587.

49.

Huang

Zhu

, et al. (2016) Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells. Autophagy 12(10): 1687–1703.

50.

Kim

Kundu

Viollet

, et al. (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 13(2): 132–141.

51.

Gong

Xiang

, et al. (2023) HNRNPA2B1-mediated m⁶A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis. Journal of Translational Medicine 21(1): 382.

52.

Liang

Wang

(2020) MiR-21-5p reduces apoptosis and inflammation in rats with spinal cord injury through PI3K/AKT pathway. Panminerva Medica 66(3): 256–265.

53.

Ren

Hou

Yang

, et al. (2019) Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. Journal of Experimental & Clinical Cancer Research 38(1): 62.

54.

Liu

Deng

Jiang

, et al. (2020) Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages. Biomedicine & Pharmacotherapy 125: 109895.

55.

Zhao

Hao

, et al. (2019) miR-21-5p regulates mycobacterial survival and inflammatory responses by targeting Bcl-2 and TLR4 in Mycobacterium tuberculosis-infected macrophages. FEBS Letters 593(12): 1326–1335.

56.

Calis

Dogan

Durdagi

, et al. (2022) A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo glioblastoma tumor growth. Cell Death Discovery 8(1): 433.

57.

Tewari

, et al. (2020) MicroRNA-21 ameliorates the impairment of autophagy in palatal wound healing. Journal of Physiology and Pharmacology 71(6): 911–918.

58.

Barz

Kriegenburg

Sánchez-Martín

, et al. (2021) Small but mighty: Atg8s and Rabs in membrane dynamics during autophagy. Biochimica et Biophysica Acta Molecular Cell Research 1868(9): 119064.

59.

Roy

Roux

(2020) Rab GTPases in osteoclastic bone resorption and autophagy. International Journal of Molecular Sciences 21(20): 7655.

60.

Huang

Zhu

, et al. (2019) Exosomes from miR-21-5p-increased neurons play a role in neuroprotection by suppressing Rab11a-mediated neuronal autophagy in vitro after traumatic brain injury. Medical Science Monitor 25: 1871–1885.

MicroRNA-21-5p regulates autophagy and apoptosis via the activation of the PI3K/AKT/mTOR signaling pathway and reducing H 2 O 2 -induced damage in primary AEC-II

Abstract

Objective:

Introduction:

Methods:

Results:

Conclusion:

Keywords

Introduction

Materials and methods

Animal and reagents

Cell culture

Immunofluorescence

Transmission electron microscopy (TEM)

CCK-8 assay

DCFH-DA (2′,7′-dichlorodihydrofluorescein) fluorimetry

MicroRNA transfection

Real-time PCR

Western blotting

MRFP-GFP-LC3 adenovirus transfection

Detection of early apoptotic cells with flow cytometry (FCM)

Statistical analysis

Results

Identification of AEC II

Changes of autophagic flux in AEC II after H2O2 stimulation

miR-21-5p up-regulation alleviates autophagy induced by H2O2 injury

miR-21-5p can reduce H2O2-induced damage by activating AKT/mTOR axis

The protective effect mediated by miR-21-5p during H2O2-induced AEC-II damage can be abolished through the inhibition of mTOR

miR-21-5p can inhibit autophagy by inhibiting the production of autolysosome

miR-21-5p can inhibit the early apoptosis of AEC-II and reduce cell damage

Discussion

Conclusion

Footnotes

Author contributions

Declaration of conflicting interests

Funding

Ethical approval

Animal welfare

Declaration of AI use

ORCID iD

Availability of data and materials

References

Changes of autophagic flux in AEC II after H₂O₂ stimulation

miR-21-5p up-regulation alleviates autophagy induced by H₂O₂ injury

miR-21-5p can reduce H₂O₂-induced damage by activating AKT/mTOR axis

The protective effect mediated by miR-21-5p during H₂O₂-induced AEC-II damage can be abolished through the inhibition of mTOR